Drugmakers Turn to AI for Drug Development Amid US Tariff Uncertainty Pharmaceutical executives are increasingly turning to artificial intelligence (AI) to revolutionize the drug development process. In a recent industry gathering, these leaders delved into the promising role of AI in expediting research, enhancing clinical trials, and ultimately bringing life-saving medications to market more efficiently. […]
Aqemia's Global Expansion Fueled by New Investments
Aqemia, a Paris-based biotechnology company, is making headlines with its ambitious plans for global expansion following a recent funding round. The company’s innovative approach seeks to revolutionize drug development using artificial intelligence, which has the potential to reshape the landscape of cancer and immuno-oncology research. Founded with the vision of accelerating drug discovery processes, Aqemia […]